{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:14:47Z","timestamp":1740107687005,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Central Clinical Hospital of the Ministry of National Defense, Military Institute of Medicine in Warsaw, Poland.","award":["0000000299"],"award-info":[{"award-number":["0000000299"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s10067-017-3670-1","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T05:45:21Z","timestamp":1494308721000},"page":"1677-1681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Recurrent infections in a patient with psoriatic arthritis and hypogammaglobulinemia, treated with conventional and biologic disease-modifying anti-rheumatic drugs\u2014a primary or secondary entity?"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8509-4453","authenticated-orcid":false,"given":"Ewa","family":"Wi\u0119sik-Szewczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Kucharczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"\u015awierkocka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Rutkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Jahnz-R\u00f3\u017cyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,9]]},"reference":[{"key":"3670_CR1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/RHU.0000000000000364","volume":"22","author":"KW Hagberg","year":"2016","unstructured":"Hagberg KW, Li L, Peng M, Paris M, Shah K, Jick SS (2016) Rates of cancers and opportunistic infections in patients with psoriatic arthritis compared with patients without psoriatic arthritis. J Clin Rheumatol 22:241\u2013247","journal-title":"J Clin Rheumatol"},{"key":"3670_CR2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/BOR.0b013e32832c792d","volume":"21","author":"N Haroon","year":"2009","unstructured":"Haroon N, Inman RD (2009) Infectious complications of biological therapy. Curr Opin Rheumatol 21:397\u2013403","journal-title":"Curr Opin Rheumatol"},{"key":"3670_CR3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semarthrit.2008.05.002","volume":"39","author":"DE Furst","year":"2009","unstructured":"Furst DE (2009) Serum immunoglobulins and risk of infection: how low can you go? Semin Arthritis Rheum 39:18\u201329","journal-title":"Semin Arthritis Rheum"},{"key":"3670_CR4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ejim.2014.09.009","volume":"25","author":"M Blot","year":"2014","unstructured":"Blot M, Boyer P, Samson M et al (2014) Should mild hypogammaglobulinemia be managed as severe hypogammaglobulinemia? A study of 389 patients with secondary hypogammaglobulinemia. Eur J Intern Med 25:837\u2013842","journal-title":"Eur J Intern Med"},{"key":"3670_CR5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jbspin.2010.09.016","volume":"78","author":"M Samson","year":"2011","unstructured":"Samson M, Audia S, Lakomy D, Bonnotte B, Tavernier C, Ornetti P (2011) Diagnostic strategy for patients with hypogammaglobulinemia in rheumatology. Joint Bone Spine 78:241\u2013245","journal-title":"Joint Bone Spine"},{"key":"3670_CR6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","volume":"112","author":"H Chapel","year":"2008","unstructured":"Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, Fieschi C, Thorn V, Abedi MR, Hammarstrom L (2008) Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 112:277\u2013286","journal-title":"Blood"},{"key":"3670_CR7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","volume":"134","author":"B Gathmann","year":"2014","unstructured":"Gathmann B, Mahlaoui N, CEREDIH et al (2014) Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 134:116\u2013126","journal-title":"J Allergy Clin Immunol"},{"key":"3670_CR8","unstructured":"ESID Working Definitions for diagnosis of PID. file:\/\/\/C:\/Users\/Samsung\/Downloads\/ESIDRegistry_ClinicalCriteria%20(5).pdf"},{"key":"3670_CR9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","volume":"4","author":"FA Bonilla","year":"2016","unstructured":"Bonilla FA, Barlan I, Chapel H et al (2016) International Consensus Document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract 4:38\u201359","journal-title":"J Allergy Clin Immunol Pract"},{"key":"3670_CR10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s10875-016-0264-7","volume":"36","author":"C Wirsum","year":"2016","unstructured":"Wirsum C, Glaser C, Gutenberger S et al (2016) Secondary antibody deficiency in glucocorticoid therapy clearly differs from primary antibody deficiency. J Clin Immunol 36:406\u2013412","journal-title":"J Clin Immunol"},{"key":"3670_CR11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/qjmed\/hcu094","volume":"107","author":"M Makatsori","year":"2014","unstructured":"Makatsori M, Kiani-Alikhan S, Manson AL et al (2014) Hypogammaglobulinaemia after rituximab treatment\u2014incidence and outcomes. QJM 107:821\u2013828","journal-title":"QJM"},{"key":"3670_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaut.2010.10.002","volume":"36","author":"J Boileau","year":"2011","unstructured":"Boileau J, Mouillot G, Gerard L et al (2011) Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study. J Autoimmun 36:25\u201332","journal-title":"J Autoimmun"},{"key":"3670_CR13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jbspin.2004.07.012","volume":"72","author":"C Sordet","year":"2005","unstructured":"Sordet C, Cantagrel A, Schaeverbeke T, Sibilia J (2005) Bone and joint disease associated with primary immune deficiencies. Joint Bone Spine 72:503\u2013514","journal-title":"Joint Bone Spine"},{"key":"3670_CR14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s10067-005-1141-6","volume":"25","author":"J Swierkot","year":"2006","unstructured":"Swierkot J, Lewandowicz-Uszynska A, Chlebicki A, Szmyrka-Kaczmarek M, Pola\u0144ska B, Jankowski A, Szechi\u0144ski J (2006) Rheumatoid arthritis in a patient with common variable immunodeficiency: difficulty in diagnosis and therapy. Clin Rheumatol 25:92\u201394","journal-title":"Clin Rheumatol"},{"key":"3670_CR15","first-page":"358","volume":"38","author":"LH Lin","year":"2005","unstructured":"Lin LH, Tsai CN, Liu MF, Wang CR (2005) Common variable immunodeficiency mimicking rheumatoid arthritis with Sj\u00f6gren\u2019s syndrome. J Microbiol Immunol Infect 38:358\u2013360","journal-title":"J Microbiol Immunol Infect"},{"key":"3670_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/s10165-011-0492-x","volume":"22","author":"AP Diamantopoulos","year":"2012","unstructured":"Diamantopoulos AP, Haugeberg G (2012) Recurrent infections in a rheumatoid arthritis patient with a primary immunodeficiency, treated with conventional and biologic disease-modifying anti-rheumatic drugs. Mod Rheumatol 22:295\u2013297","journal-title":"Mod Rheumatol"},{"key":"3670_CR17","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.autrev.2014.04.006","volume":"13","author":"X Xiao","year":"2014","unstructured":"Xiao X, Miao Q, Chang C, Gershwin ME, Ma X (2014) Common variable immunodeficiency and autoimmunity\u2014an inconvenient truth. Autoimmun Rev 13:858\u2013864","journal-title":"Autoimmun Rev"},{"key":"3670_CR18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10067-016-3229-6","volume":"35","author":"VR Dimitriades","year":"2016","unstructured":"Dimitriades VR, Sorensen R (2016) Rheumatologic manifestations of primary immunodeficiency diseases. Clin Rheumatol 35:843\u2013850","journal-title":"Clin Rheumatol"},{"key":"3670_CR19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.biologicals.2008.07.002","volume":"36","author":"ER Stiehm","year":"2008","unstructured":"Stiehm ER, Keller MA, Vyas GN (2008) Preparation and use of therapeutic anti-bodies primarily of human origin. Biologicals 36:363\u2013374","journal-title":"Biologicals"},{"key":"3670_CR20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2500\/aap.2016.37.3987","volume":"37","author":"FA Bonilla","year":"2016","unstructured":"Bonilla FA (2016) Intravenous and subcutaneous immunoglobulin G replacement therapy. Allergy Asthma Proc 37:426\u2013431","journal-title":"Allergy Asthma Proc"},{"key":"3670_CR21","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jaci.2010.02.040","volume":"125","author":"M Lucas","year":"2010","unstructured":"Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H (2010) Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22\u00a0years. J Allergy Clin Immunol 125:1354\u20131360.e4","journal-title":"J Allergy Clin Immunol"},{"key":"3670_CR22","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1182\/blood-2012-05-431064","volume":"120","author":"I Quinti","year":"2012","unstructured":"Quinti I, Agostini C, Tabolli S, Brunetti G, Cinetto F, Pecoraro A, Spadaro G (2012) Malignancies are the major cause of death in patients with adult onset common variable immunodeficiency. Blood 120:1953\u20131954","journal-title":"Blood"},{"key":"3670_CR23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/blood-2015-05-647552","volume":"127","author":"EM Ammann","year":"2016","unstructured":"Ammann EM, Jones MP, Link BK et al (2016) Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy. Blood 127:200\u2013207","journal-title":"Blood"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3670-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3670-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3670-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T08:08:45Z","timestamp":1497600525000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3670-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,9]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["3670"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3670-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2017,5,9]]}}}